Everpar Advisors LLC Invests $1.45 Million in The Procter & Gamble Company (NYSE:PG)

Everpar Advisors LLC purchased a new stake in shares of The Procter & Gamble Company (NYSE:PG) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 9,925 shares of the company’s stock, valued at approximately $1,454,000. Procter & Gamble makes up 0.7% of Everpar Advisors LLC’s holdings, making the stock its 24th biggest holding.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PG. Wyrmwood Management LLC bought a new stake in Procter & Gamble in the fourth quarter worth $29,000. Naples Money Management LLC bought a new position in Procter & Gamble during the 4th quarter valued at about $29,000. Criterion Capital Advisors LLC purchased a new stake in Procter & Gamble in the 4th quarter worth about $33,000. MeadowBrook Investment Advisors LLC purchased a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $33,000. Finally, Pacific Capital Wealth Advisors Inc. bought a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $35,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Performance

NYSE:PG traded down $0.71 during mid-day trading on Wednesday, hitting $165.05. The company’s stock had a trading volume of 4,579,411 shares, compared to its average volume of 6,870,830. The business’s fifty day moving average is $160.23 and its two-hundred day moving average is $154.49. The stock has a market cap of $389.54 billion, a price-to-earnings ratio of 26.97, a PEG ratio of 3.34 and a beta of 0.43. The Procter & Gamble Company has a 1 year low of $141.45 and a 1 year high of $166.37. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.10. The company had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. Procter & Gamble’s quarterly revenue was up .6% on a year-over-year basis. During the same period last year, the business earned $1.37 earnings per share. Analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $1.0065 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.44%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is 65.69%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and increased their target price for the stock from $160.00 to $175.00 in a research note on Monday, March 11th. Raymond James raised their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. JPMorgan Chase & Co. lowered their price target on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a report on Thursday, January 18th. Royal Bank of Canada raised their target price on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 24th. Finally, UBS Group lifted their target price on Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $169.76.

Insider Transactions at Procter & Gamble

In other news, CEO Gary A. Coombe sold 21,388 shares of the business’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $164.98, for a total transaction of $3,528,592.24. Following the completion of the sale, the chief executive officer now owns 36,854 shares of the company’s stock, valued at $6,080,172.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Gary A. Coombe sold 21,388 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $164.98, for a total value of $3,528,592.24. Following the transaction, the chief executive officer now directly owns 36,854 shares of the company’s stock, valued at $6,080,172.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the sale, the insider now directly owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The disclosure for this sale can be found here. Insiders have sold a total of 140,112 shares of company stock valued at $22,841,321 in the last ninety days. 0.17% of the stock is currently owned by corporate insiders.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.